Covered warrant

Clover Health Investments, Corp. Announces Redemption of All Outstanding Warrants

Retrieved on:

Thursday, July 22, 2021

Finance, Money, Corporate finance, Equity securities, Options, Financial markets, Warrant, Arrest warrant, Stock option expensing, Covered warrant

In addition, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the Private Warrants and, together with the Public Warrants, the Warrants) on the same terms as the outstanding Public Warrants.

Key Points:

In addition, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the Private Warrants and, together with the Public Warrants, the Warrants) on the same terms as the outstanding Public Warrants.
At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants.
The Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants.
Clover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans.

Hims & Hers Announces Redemption of All Outstanding Warrants

Retrieved on:

Friday, July 9, 2021

As previously announced, in February 2021 all of the outstanding Private Placement Warrants (as defined in the Warrant Agreement) were net exercised.

Key Points:

As previously announced, in February 2021 all of the outstanding Private Placement Warrants (as defined in the Warrant Agreement) were net exercised.
At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants.
In addition, the New York Stock Exchange intends to halt trading on the Public Warrants after close of market on August 6.
The Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants.

Hydrofarm Announces Redemption of Investor Warrants

Retrieved on:

Monday, June 21, 2021

Financial markets, Corporate finance, Finance, Money, Equity securities, Options, Stock market, Warrant, Stock, Stock option expensing, Covered warrant

Holders of the Investor Warrants have until 5:00 p.m. Eastern Time on July 19, 2021 to exercise their Investor Warrants.

Key Points:

Holders of the Investor Warrants have until 5:00 p.m. Eastern Time on July 19, 2021 to exercise their Investor Warrants.
Following the redemption, and assuming all outstanding Investor Warrants are exercised, Hydrofarm expects to have approximately 43.2 million shares of common stock outstanding.
Under the terms of the Investor Warrants, Hydrofarm is entitled to redeem all of the outstanding Investor Warrants for a redemption price of $0.00033712 per Investor Warrant if (i) there is an effective registration statement covering the resale of the shares of common stock underlying the Investor Warrants, and (ii)the volume-weighted average price of the Companys common stock for the twenty (20) consecutive trading days prior to the date of the notice of redemption is at least $25.28.
Any Investor Warrants that remain unexercised immediately after 5:00 p.m. Eastern Time on July 19, 2021, the redemption date, will be void and no longer exercisable, and the holders of those Investor Warrants will be entitled to receive $0.00033712 per Investor Warrant.

Amarillo updates share capital after exercise of warrants and options

Retrieved on:

Wednesday, June 16, 2021

Options, Finance, Corporate finance, Equity securities, Money, Financial markets, Warrant, Covered warrant, Stock option expensing

Amarillo issued 1,355,940 common shares of the Company and 1,355,940 common share purchase warrants upon the exercise of the CPUs; each warrant is exercisable to acquire one common share at a price of $0.30 until August 29, 2021.

Key Points:

Amarillo issued 1,355,940 common shares of the Company and 1,355,940 common share purchase warrants upon the exercise of the CPUs; each warrant is exercisable to acquire one common share at a price of $0.30 until August 29, 2021.
The 149,000 warrants were part of the 50,025,000 common share purchase warrants issued on August 29, 2019, at $0.30 per warrant as part of private placements that raised gross proceeds of $10,005,000.
The exercise of the CPUs, warrants, and stock options have generated overall proceeds of $400,788.
There are 51,380,940 warrants at an exercise price of $0.30 expiring on August 29, 2021, and 20,320,000 options outstanding.

Opendoor Technologies Inc. Announces Redemption of All Outstanding Warrants

Retrieved on:

Wednesday, June 9, 2021

Finance, Money, Corporate finance, Equity securities, Options, Financial markets, Warrants, Arrest warrant, Stock option expensing, Covered warrant

In addition, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the Private Warrants and, together with the Public Warrants, the Warrants) on the same terms as the outstanding Public Warrants.

Key Points:

In addition, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the Private Warrants and, together with the Public Warrants, the Warrants) on the same terms as the outstanding Public Warrants.
At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants.
The Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants.
Questions concerning redemption and exercise of the Warrants can be directed to our information agent, D.F.

Vincerx Pharma Announces Redemption of Public Warrants

Retrieved on:

Monday, April 5, 2021

Equity securities, Options, Corporate finance, Finance, Money, Warrant, Financial economics, Covered warrant, Stock option expensing

At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants.

Key Points:

At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants.
This means that only an even number of Public Warrants may be exercised at any given time by a holder.
Any Public Warrants that remain unexercised following 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable, and the holders of those Public Warrants will be entitled to receive only the redemption price of $0.01 per warrant.
Forward-looking statements include, but are not limited to, statements regarding the redemption of the Public Warrants and the expected proceeds from the exercise of the Public Warrants.

Nextleaf Announces Launch of Early Warrant Exercise Incentive Program and Repricing

Retrieved on:

Tuesday, March 23, 2021

Options, Equity securities, Finance, Corporate finance, Money, Warrant, Financial economics, Incentive program, Stock option expensing, Covered warrant

Under the incentive program, the Company is offering an inducement to each Warrantholder who exercises their Warrants prior to May 15, 2021.

Key Points:

Under the incentive program, the Company is offering an inducement to each Warrantholder who exercises their Warrants prior to May 15, 2021.
All Warrants exercised prior to May 15, 2021 will receive one additional share purchase warrant (each, an "Incentive Warrant") for each Warrant exercised.
Each Incentive Warrant will entitle the holder to purchase one additional Share at $0.35 per Share until May 15, 2022 (the "Term"), subject to acceleration.
Any Shares issued upon exercise of the Incentive Warrants will be subject to a statutory four-month and one day hold period from the date of issuance of the Incentive Warrants.

Desktop Metal, Inc. Announces Redemption of Public Warrants

Retrieved on:

Friday, February 26, 2021

At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants.

Key Points:

At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants.
The Public Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such warrants, at the exercise price of $11.50 per share.
Any Public Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable, and the holders of those Public Warrants will be entitled to receive only the redemption price of $0.01 per warrant.
None of the Company, its board of directors or employees has made or is making any representation or recommendation to any holder of the Public Warrants as to whether to exercise or refrain from exercising any Public Warrants.

Personas Social Receives Approval of Warrant Term Extension

Retrieved on:

Thursday, February 11, 2021

Professional services, Online Retail, Retail, Technology, Finance, Internet, Banking, Corporate finance, Equity securities, Options, Finance, Money, Warrant, Forward-looking statement, Economy, Covered warrant

Each Unit consisted of one common share and one half of one common share purchase warrant for a total of 21,670,670 warrants (the Warrants).

Key Points:

Each Unit consisted of one common share and one half of one common share purchase warrant for a total of 21,670,670 warrants (the Warrants).
Each Warrant entitled the holder thereof to acquire one additional common share of the Company at a price of $0.075 per common share for a period of 12 months from the date of issuance.
The Exchange has approved the extension for the expiry date of the Warrants for six (6) months.
Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.

Isracann Announces Launch of Early Warrant Exercise Incentive Program and Repricing

Retrieved on:

Monday, January 11, 2021

Options, Equity securities, Finance, Money, Corporate finance, Warrant, Financial economics, Covered warrant, Stock option expensing

Under the incentive program, the Company is offering an inducement to each Warrantholder who exercises their Warrants prior to March 31, 2021.

Key Points:

Under the incentive program, the Company is offering an inducement to each Warrantholder who exercises their Warrants prior to March 31, 2021.
All Warrants exercised prior to March 31, 2021 will receive one additional share purchase warrant (each, an Incentive Warrant) for each Warrant exercised.
Each Incentive Warrant will entitle the holder to purchase one additional Share at $0.50 per Share for 24 months from the date of issuance.
Any Shares issued upon exercise of the Incentive Warrants will be subject to a four-month hold period from the date of issuance of the Incentive Warrants.